Your browser doesn't support javascript.
loading
Impact of perioperative chemotherapy on survival in patients with advanced primary urethral cancer: results of the international collaboration on primary urethral carcinoma.
Gakis, G; Morgan, T M; Daneshmand, S; Keegan, K A; Todenhöfer, T; Mischinger, J; Schubert, T; Zaid, H B; Hrbacek, J; Ali-El-Dein, B; Clayman, R H; Galland, S; Olugbade, K; Rink, M; Fritsche, H-M; Burger, M; Chang, S S; Babjuk, M; Thalmann, G N; Stenzl, A; Efstathiou, J A.
Afiliação
  • Gakis G; Department of Urology, University of Tuebingen, Tuebingen, Germany georgios.gakis@googlemail.com.
  • Morgan TM; Department of Urology, University of Michigan, Ann Arbor, USA.
  • Daneshmand S; Institute of Urology, USC/Norris Comprehensive Cancer Center, Los Angeles.
  • Keegan KA; Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, USA.
  • Todenhöfer T; Department of Urology, University of Tuebingen, Tuebingen, Germany.
  • Mischinger J; Department of Urology, University of Tuebingen, Tuebingen, Germany.
  • Schubert T; Department of Urology, University of Tuebingen, Tuebingen, Germany.
  • Zaid HB; Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, USA.
  • Hrbacek J; 2nd Medical School, Department of Urology, Charles University, Prague, Czech Republic.
  • Ali-El-Dein B; Urology and Nephrology Center, Mansoura Clinic, Mansoura, Egypt.
  • Clayman RH; Department of Radiooncology, Massachusetts General Hospital, Harvard Medical School, Boston, USA.
  • Galland S; Department of Radiooncology, Massachusetts General Hospital, Harvard Medical School, Boston, USA.
  • Olugbade K; Department of Urology, University of Michigan, Ann Arbor, USA.
  • Rink M; Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg.
  • Fritsche HM; Department of Urology, University Hospital Regensburg, Regensburg, Germany.
  • Burger M; Department of Urology, University Hospital Regensburg, Regensburg, Germany.
  • Chang SS; Department of Urologic Surgery, Vanderbilt University Medical Center, Nashville, USA.
  • Babjuk M; 2nd Medical School, Department of Urology, Charles University, Prague, Czech Republic.
  • Thalmann GN; Department of Urology, University Hospital Bern, Bern, Switzerland.
  • Stenzl A; Department of Urology, University of Tuebingen, Tuebingen, Germany.
  • Efstathiou JA; Department of Radiooncology, Massachusetts General Hospital, Harvard Medical School, Boston, USA.
Ann Oncol ; 26(8): 1754-9, 2015 Aug.
Article em En | MEDLINE | ID: mdl-25969370
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Uretra / Neoplasias Uretrais / Carcinoma de Células Escamosas / Carcinoma de Células de Transição / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Quimioterapia Adjuvante / Terapia Neoadjuvante / Quimiorradioterapia Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Alemanha
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Uretra / Neoplasias Uretrais / Carcinoma de Células Escamosas / Carcinoma de Células de Transição / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Quimioterapia Adjuvante / Terapia Neoadjuvante / Quimiorradioterapia Tipo de estudo: Observational_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Ann Oncol Assunto da revista: NEOPLASIAS Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Alemanha